Sofosbuvir’s hepatoprotective efficacy in rats is enhanced by encapsulating in taurocholate-stabilized galactose-anchored bilosomes

Sofosbuvir’s hepatoprotective efficacy in rats is enhanced by encapsulating in taurocholate-stabilized galactose-anchored bilosomes

Abstract Background In conjunction with other antiviral medicines, sofosbuvir (SOF) is an essential therapy for chronic hepatitis C. There is some debate over its influence on hepatic fibrosis. The use of nanotechnology in treatment has gained popularity, with the goal of delivering therapeutic subs...

Full description

Bibliographic Details
Main Authors: Marwa Khaled Mohsen, Soheir Abo El azm Diab, Amani N. Shafik, Ahmed H. Osman, Marianne J. Naguib, Amira M. Kamel, Marwa Nagi Mehesen
Format: Article
Language:English
Published: SpringerOpen 2025-02-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Bilosomal formulation
Galactose
Taurocholate
Hepatic fibrosis
Sofosbuvir
Thioacetamide
Online Access:https://doi.org/10.1186/s43094-025-00775-w

Internet

https://doi.org/10.1186/s43094-025-00775-w

Similar Items